Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
A2B covalent ligand (AC140)
Cat.#: ASSD-140
Specifications
Description A2B covalent ligand selectively targets lysine residue(s) on the receptor and binds persistently in radioligand displacement and wash-out assays, allowing for novel ways to interrogate the A2BAR. Apparent pKi values at A2BARs are 8.10 and 9.17 (after 4h), where a Ki shift indicates a covalent mode of action.
Displays ~100 -fold selectivity for A2B compared to A1, A2A and A3 receptors.Size 50 μg Chemical Name 4-(2,6-dioxo-1-propyl-2,3,6,7-tetrahydro-1H-purin-8-yl)benzenesulfonyl fluoride Molecule Weight 352.3 Molecular formula C14H13FN4O4S Purity >95% Solubility Soluble in DMSO Storage Store at -20° C Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-110 Picro Sirius Red Stain Kit (AC110) 1 kit, 100 tests inquiry ASSD-187 Quinaldine Red (AC187) 5 g, 25 g, 100 g, 250 g inquiry ASSD-202 5(6)-Carboxytetramethylrhodamine (AC202) 100 mg, 250 mg inquiry ASSD-175 5-Carboxyfluorescein-N-hydroxysuccinimide Ester (AC175) 25 mg inquiry ASSD-194 7-(Diethylamino)coumarin-3-carboxylic acid (AC194) 100 mg inquiry ASSD-218 6-Carboxy-2′,7′-dichlorofluorescein-3′,6′-diacetatesuccinimidyl Ester (AC218) 25 mg inquiry ASSD-174 Coomassie Blue R-250 (AC174) 25 g, 100 g inquiry ASSD-228 ImmunoHistoMount (AC228) 30 ml inquiry ASSD-120 Fluorescent adenosine antagonist [XAC] (AC120) 500 μg inquiry ASSD-154 Brilliant Blue R-250 (AC154) 1g, 5g inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket